 NEW YORK, April 5, 2021 PRNewswire -- Hoth Therapeutics, Inc. Nasdaq: HOTH, a patient-focused clinical-stage biopharmaceutical company, today announced that the Brazilian Patent Office has issued a notice of allowance for a patent application related to the Companys method for inhibiting formation of biofilms. The notice of allowance was issued March 31, 2021 and is related to a new patent application not previously announced. 